INTEGRATED BIOPHARMA INC

INBP · OTC · SIC 2834: Pharmaceutical Preparations
275
SEC Filings

Business Summary

Integrated BioPharma, Inc. is a Delaware corporation engaged in manufacturing, distributing, marketing, and selling vitamins, nutritional supplements, and herbal products. Its Contract Manufacturing segment, operated by Manhattan Drug Company, Inc. (MDC), serves distributors, multilevel marketers, and specialized health-care providers. Its Other Business Lines segment includes warehousing, fulfillment services, and raw material distribution. Major customers include Life Extension and Herbalife, representing approximately 84% of consolidated net sales in fiscal year 2025.

Next Earnings

Q2 FY2026 — expected 2026-09-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionINBPdiscussed_in_filing Cybersecurity
topic_mentionINBPdiscussed_in_filing Trusted Computing
topic_mentionINBPdiscussed_in_filing Blockchain & Crypto
topic_mentionINBPdiscussed_in_filing Capital Expenditure
topic_mentionINBPdiscussed_in_filing Supply Chain
topic_mentionINBPdiscussed_in_filing Regulation
topic_mentionINBPdiscussed_in_filing Healthcare & Bio
topic_mentionINBPdiscussed_in_filing Sovereign & Government
topic_mentionINBPdiscussed_in_filing Cybersecurity
topic_mentionINBPdiscussed_in_filing Trusted Computing
topic_mentionINBPdiscussed_in_filing Blockchain & Crypto
topic_mentionINBPdiscussed_in_filing Capital Expenditure
topic_mentionINBPdiscussed_in_filing Supply Chain
topic_mentionINBPdiscussed_in_filing Regulation
topic_mentionINBPdiscussed_in_filing Healthcare & Bio
topic_mentionINBPdiscussed_in_filing Sovereign & Government
topic_mentionINBPdiscussed_in_filing Cybersecurity
topic_mentionINBPdiscussed_in_filing Trusted Computing
topic_mentionINBPdiscussed_in_filing Blockchain & Crypto
topic_mentionINBPdiscussed_in_filing Capital Expenditure

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-09-232025-06-300001437749-25-029711EDGAR33K words
2024-09-202024-06-300001437749-24-029768EDGAR—
2023-09-152023-06-300001437749-23-026022EDGAR—
2022-09-132022-06-300001437749-22-022334EDGAR—
2021-09-022021-06-300001437749-21-021375EDGAR—
2020-09-232020-06-300001437749-20-020123EDGAR—
2019-08-292019-06-300001437749-19-017611EDGAR—
2018-09-122018-06-300001437749-18-016922EDGAR—
2017-09-012017-06-300001437749-17-015520EDGAR—
2016-09-022016-06-300001437749-16-038298EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-112025-12-310001437749-26-003803EDGAR18K words
2025-11-102025-09-300001437749-25-034076EDGAR—
2025-05-142025-03-310001437749-25-016802EDGAR—
2025-02-132024-12-310001437749-25-003744EDGAR—
2024-11-132024-09-300001437749-24-034953EDGAR—
2024-05-102024-03-310001437749-24-016015EDGAR—
2024-02-122023-12-310001437749-24-003756EDGAR—
2023-11-092023-09-300001437749-23-031168EDGAR—
2023-05-112023-03-310001437749-23-013885EDGAR—
2023-02-102022-12-310001437749-23-003051EDGAR—
2022-11-102022-09-300001437749-22-026976EDGAR—
2022-05-122022-03-310001437749-22-012079EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-180001437749-26-004553EDGAR1K words
2026-02-110001437749-26-003808EDGAR—
2025-12-010001437749-25-036573EDGAR—
2025-11-100001437749-25-034091EDGAR—
2025-09-230001437749-25-029717EDGAR—
2025-05-140001437749-25-016809EDGAR—
2025-04-240001437749-25-012917EDGAR—
2025-04-210001437749-25-012475EDGAR—
2025-02-130001437749-25-003765EDGAR—
2024-12-020001437749-24-036441EDGAR—

275 total filings indexed. 243 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

contract-manufacturing-of-dietary-supplements warehousing-and-fulfillment-services raw-material-distribution united-states luxembourg fda-good-manufacturing-practices-(gmp)---21-cfr-part-111 dietary-supplement-health-and-education-act-(dshea) united-states-pharmacopoeia-convention-(usp)-guidelines nutrition,-labeling-and-education-act-(nlea)

Company Identity

CIK0001016504
TickerINBP
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 3e2e872e6b7c0d79feea9cef66814fa82a606dded83d9761335c31e43ccaafca
parent: 6c7e07d784d583089c5a5d901de893d9f560e626df22b942c4c251146aaec8a9
content hash: 0fa8e08fda2be0b7d76b4571271166c492303c8aef6f660980a2642decbbebd8
signed: 2026-04-13T04:45:41.239Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf